490 likes | 2.35k Views
Basic Concept. DLgas may be affected by: Vgas (ml/min) PAgas-Pcgas (mmHg)?DLgas = Vgas(STPD)/(PAgas-Pcgas)Choice of gas: may diffuse along the A-c pathway could be transported by hemoglobin?O2 and CO. Basic Concept. Why do we choose CO? 1.PcO2 value are not constant 2.High affinity to hemoglobin (210 times) ? PcCO =0 mmHgDLCO = Vco(STPD)/PACO .
E N D
1. DLCOcarbon monoxide diffusing capacity
Reporter: Ri ???
91-6-17
2. Basic Concept DLgas may be affected by:
Vgas (ml/min)
PAgas-Pcgas (mmHg)
?DLgas = Vgas(STPD)/(PAgas-Pcgas)
Choice of gas:
may diffuse along the A-c pathway
could be transported by hemoglobin
?O2 and CO
3. Basic Concept Why do we choose CO?
1.PcO2 value are not constant
2.High affinity to hemoglobin (210 times)
? PcCO =0 mmHg
DLCO = Vco(STPD)/PACO
4. Basic Concept
5. Affecting Factor For DLCO A-c surface area
Thickness of the alveolocapillary membrane
Reaction rate of CO with hemoglobin
Pulmonary capillary blood volume
Lung volume
V/Q mismatch
Altitude
Body position
6. DLCO Method Single-breath method (DLCO - SB)
Steady-state method (DLCO - SS)
Rebreathing method (DLCO - RB)
7. DLCO - SB
8. Breathing maneuver 1.exhale down to the RV level
2.single, rapid inspiratory VC maneuver and hold in the breath for a period of time (THold)
3.exhale rapidly back down to the RV level
9. Alveolar gas sampling is performed after the first approximately 1000ml are exhaled.
Gas mixture: 0.3% CO, 10% He, room air
11. Calculation FACOI = FICO * (FEHe/FIHe)
VA (STPD) = VVC (STPD) * (FIHe/FEHe)
?VVC (STPD) = VVC (ATPS) * STPD factor
(Patm-PH2O) 273
= VVC (ATPS) * [--------------- * -----------]
760 (273+T)
12. Calculation FACOF = FACOI * e (KTHold)
K= DLCO * (Patm-PH2O) / (VA * 60)
DLCO – SB =
VA (STPD) * 60 FACOI
------------------------ * Ln ---------
(Patm-PH2O)(THold) FACOF
13. Hb correction Hb correction factor = 1 / (0.07 * gm Hb)
Adjusted DLCO = measured DLCO * Hb correction factor
14. Advantages No invasive measuring procedures
Analysis of only two gases is required
Test is easily and rapidly performed
15. Disadvantages Difficult breathing maneuver
Not practical during exercise testing
Less than maximal inspired VC volumes affect measurement accuracy
V/Q mismatches can affect the results
16. DLCO - SS
17. Breathing maneuver: normal tidal breathing
Method:
During the last two minutes of breathing (Tcol)
Exhaled air is collected in a Douglas bag
A sample volume (Vsam) is taken from this bag
FECO, FECO2, FEN2
Gas mixture: 0.1% CO, balance air
18. Calculation DLCO – SS = VCO (STPD) / PACO
VCO (STPD)
VE (ATPS) = (Vcol + Vsam) / Tcol
VE (STPD) = VE (ATPS) * STPD factor
VCO (STPD) = VE (STPD) * (FACO – FECO)
FACO = FICO * (FEN2 / FIN2)
FIN2 = 1- (FIO2 + FICO2)
FEN2 = 1- (FEO2 + FECO2)
19. PACO detection method PACO is more difficult because sample is contaminated with gas from the subject’s physiologic deadspace volume (VD)
Deadspace – compensated techniques
Estimated – deadspace technique
Assumed – deadspace technique
Alveolar gas sampling technique
20. Estimated – deadspace technique FACO2 = PaCO2 / (Patm – PH2O)
VD FACO2 – FECO2 FACO – FECO
----- = ---------------------- = --------------------VT FACO2 FACO – FICO
21. Estimated – deadspace technique FACO2
FACO = (FICO - ----------) * (FICO-FECO)
FECO2
PACO = (Patm - PH2O) * FACO
22. Assumed – deadspace technique (VT * FECO) – (VD * FICO)
FACO = -----------------------------------
VT – VD
PACO = (P Atm – P H2O) * FACO
23. Alveolar gas sampling technique Direct sampling of the subject’s end-tidal exhaled air during the last two minutes of the steady-state procedure ? PetCO
PetCO = PACO (assume)
Contraindication
Small or uneven tidal breathing volumes
During exercise
24. DLCO - SS Advantages
Natural breathing maneuver
Allow greater variety of clinical conditions
Disadvantages
More complex and difficult to perform (PACO)
PCCO back pressure
More affected by V/Q abnormalities
25. Deadspace – compensated technique Advantage
Avoids errors that can occur with end-tidal PACO measurement
Disadvantage
Misestimation of VD can result in inaccurate PACO
26. Estimated – deadspace technique Advantage
More accurate value for VD
Disadvantage
Requires an ABG sample
27. Assumed – deadspace technique Advantage
Avoid ABG sampling
Disadvantage
Greater risk of VD misestimation
28. Alveolar gas sampling technique Advantage
Avoids errors associated with VD misestimation
Disadvantage
Possible error in assuming that PetCO is equivalent to the mean PACO value
29. DLCO - RB
30. Breathing maneuver Exhales down to the RV level
Keep 30 tidal breaths / min as possible
The reservoir must be emptied completely with each inspiration
Gas mixture: 0.3% CO, 10% He, balanced air
Volume: equal to the subject’s FEV1
31. Rebreathing method techniques Reservoir – sampling technique
Washout – sampling technique
32. Advantages Least affected by
V / Q abnormalities
Changes in the subject’s lung volume at the time of measurement
33. Disadvantages Complexity of the instrumentation and equations required
Affected by PCCO buildup
Need for subject cooperation with breathing
PCCO back pressure
34. Overview of the DLCO method
35. Single – breath methods Simplest of all methods
Perform a potentially difficult breathing maneuver
Moderately affected by V /Q abnormalities
Change in lung volume at the time of measurement can significantly affect test results
36. Steady – state methods Natural subject breathing
Procedures are moderately complex
Most likely to be affected by V / Q abnormalities
37. Rebreathing methods Least affected by V / Q abnormalities
Most complex of all the methods
38. Conditions that produce changes in DLCO
39. Increased DLCO Left-to-right cardiovascular shunt
Living at high altitude
Exercise
Left heart failure
Supine position
Early polycythemia
40. Decreased DLCO Emphysema
Pulmonary resection
Chronic hypersensitivity pneumonitis
Lymphangitic spread of carcinoma
Hamman-Rich disease (chronic interstitial pneumonitis)
Histiocytosis
41. Decreased DLCO Oxygen toxicity
Radiation-induced fibrosis
Sarcoidosis
Scleroderma lung disease
SLE
Pulmonary alveolar proteinosis
Anemia
42. Decreased DLCO Pulmonary emboli
Early collagen-vascular disorders
Early miliary TB
Early sarcoidosis
43. Severity for diffusion disorders
44. Thanks for your attention